日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/16 | 3,948 | 4,012 | 3,910 | 4,009 | +71 | +1.8% | 404,500 |
| 2024/10/15 | 3,950 | 3,959 | 3,922 | 3,938 | +10 | +0.3% | 251,100 |
| 2024/10/11 | 3,948 | 3,976 | 3,922 | 3,928 | -60 | -1.5% | 257,600 |
| 2024/10/10 | 4,014 | 4,055 | 3,983 | 3,988 | -15 | -0.4% | 277,400 |
| 2024/10/09 | 4,009 | 4,030 | 3,974 | 4,003 | +32 | +0.8% | 215,400 |
| 2024/10/08 | 4,039 | 4,076 | 3,964 | 3,971 | -129 | -3.1% | 444,800 |
| 2024/10/07 | 4,037 | 4,112 | 4,010 | 4,100 | +100 | +2.5% | 420,800 |
| 2024/10/04 | 3,948 | 4,005 | 3,947 | 4,000 | +34 | +0.9% | 428,700 |
| 2024/10/03 | 3,920 | 3,980 | 3,886 | 3,966 | +98 | +2.5% | 380,500 |
| 2024/10/02 | 3,852 | 3,888 | 3,838 | 3,868 | +16 | +0.4% | 367,300 |
| 2024/10/01 | 3,726 | 3,896 | 3,711 | 3,852 | +126 | +3.4% | 338,400 |
| 2024/09/30 | 3,723 | 3,761 | 3,695 | 3,726 | -89 | -2.3% | 392,800 |
| 2024/09/27 | 3,828 | 3,862 | 3,781 | 3,815 | -90 | -2.3% | 462,700 |
| 2024/09/26 | 3,834 | 3,927 | 3,824 | 3,905 | +39 | +1% | 994,100 |
| 2024/09/25 | 3,629 | 3,906 | 3,586 | 3,866 | +478 | +14.1% | 2,115,800 |
| 2024/09/24 | 3,380 | 3,430 | 3,373 | 3,388 | +17 | +0.5% | 324,900 |
| 2024/09/20 | 3,397 | 3,423 | 3,368 | 3,371 | -18 | -0.5% | 400,900 |
| 2024/09/19 | 3,395 | 3,432 | 3,388 | 3,389 | +38 | +1.1% | 254,200 |
| 2024/09/18 | 3,349 | 3,379 | 3,331 | 3,351 | +11 | +0.3% | 213,100 |
| 2024/09/17 | 3,378 | 3,390 | 3,316 | 3,340 | -4 | -0.1% | 218,300 |
| 2024/09/13 | 3,380 | 3,393 | 3,336 | 3,344 | -55 | -1.6% | 241,600 |
| 2024/09/12 | 3,411 | 3,443 | 3,376 | 3,399 | +14 | +0.4% | 260,000 |
| 2024/09/11 | 3,454 | 3,460 | 3,367 | 3,385 | -51 | -1.5% | 258,100 |
| 2024/09/10 | 3,431 | 3,482 | 3,430 | 3,436 | -30 | -0.9% | 301,900 |
| 2024/09/09 | 3,450 | 3,493 | 3,428 | 3,466 | -39 | -1.1% | 231,300 |
| 2024/09/06 | 3,577 | 3,579 | 3,491 | 3,505 | -21 | -0.6% | 219,800 |
| 2024/09/05 | 3,494 | 3,539 | 3,470 | 3,526 | +38 | +1.1% | 272,000 |
| 2024/09/04 | 3,510 | 3,578 | 3,474 | 3,488 | -92 | -2.6% | 419,900 |
| 2024/09/03 | 3,493 | 3,593 | 3,489 | 3,580 | +119 | +3.4% | 259,100 |
| 2024/09/02 | 3,526 | 3,526 | 3,430 | 3,461 | -51 | -1.5% | 277,500 |
| 2024/08/30 | 3,522 | 3,527 | 3,490 | 3,512 | -2 | -0.1% | 362,200 |
| 2024/08/29 | 3,563 | 3,563 | 3,481 | 3,514 | -58 | -1.6% | 353,500 |
| 2024/08/28 | 3,601 | 3,609 | 3,525 | 3,572 | -58 | -1.6% | 379,000 |
| 2024/08/27 | 3,521 | 3,630 | 3,521 | 3,630 | +137 | +3.9% | 324,000 |
| 2024/08/26 | 3,510 | 3,519 | 3,476 | 3,493 | -34 | -1% | 234,400 |
| 2024/08/23 | 3,548 | 3,570 | 3,527 | 3,527 | -23 | -0.6% | 229,400 |
| 2024/08/22 | 3,458 | 3,559 | 3,458 | 3,550 | +113 | +3.3% | 310,400 |
| 2024/08/21 | 3,449 | 3,510 | 3,420 | 3,437 | -57 | -1.6% | 391,000 |
| 2024/08/20 | 3,428 | 3,510 | 3,414 | 3,494 | +127 | +3.8% | 314,100 |
| 2024/08/19 | 3,394 | 3,424 | 3,345 | 3,367 | -17 | -0.5% | 365,000 |
| 2024/08/16 | 3,375 | 3,416 | 3,338 | 3,384 | +57 | +1.7% | 431,800 |
| 2024/08/15 | 3,321 | 3,341 | 3,303 | 3,327 | -14 | -0.4% | 272,200 |
| 2024/08/14 | 3,392 | 3,420 | 3,324 | 3,341 | -52 | -1.5% | 315,400 |
| 2024/08/13 | 3,254 | 3,397 | 3,250 | 3,393 | +156 | +4.8% | 597,500 |
| 2024/08/09 | 3,259 | 3,375 | 3,204 | 3,237 | -39 | -1.2% | 773,200 |
| 2024/08/08 | 3,378 | 3,378 | 3,213 | 3,276 | +248 | +8.2% | 912,400 |
| 2024/08/07 | 3,005 | 3,148 | 2,964 | 3,028 | -47 | -1.5% | 542,900 |
| 2024/08/06 | 3,012 | 3,193 | 3,011 | 3,075 | +174.5 | +6% | 534,100 |
| 2024/08/05 | 3,047 | 3,129 | 2,875 | 2,900.5 | -327.5 | -10.1% | 710,400 |
| 2024/08/02 | 3,287 | 3,295 | 3,222 | 3,228 | -146 | -4.3% | 371,600 |
151～
200
件表示中 / 3710件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 356,100円 | +8.0% | -15.3% | 3.48% | 10.00倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 76,000円 | -11.0% | +206.6% | 0.00% | 7.55倍 | 1.78倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 341,300円 | +3.8% | -19.9% | 3.98% | 11.16倍 | 0.85倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 175,400円 | +5.0% | +1.5% | 0.00% | 15.00倍 | 3.99倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サンバイオ | 301,500円 | - | - | 0.00% | - | 139.65倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
